Table 5.
The effect of albumin supplementation for hypoalbuminemia on the results of the study.
| Variable | Albumin supplementation (A) (n = 280) |
No albumin supplementation (B) (n = 280) |
P univariate | P multivariate |
|---|---|---|---|---|
| Mechanical ventilation time % | 43.1 (7.9–77.8) | 32.9 (0–66.6) | 0.01 | 0.57 |
| Vasoactive drugs time, % | 18.4 (4.1–40.4) | 13.3 (0.7–34.4) | 0.03 | 0.89 |
| AKI, n (%) | 217 (80.3) | 195 (69.6) | 0.04 | 0.06 |
| ICU stay, day, median (IQR) | 10.6 (4.4–18.6) | 5.2 (2.6–11.6) | < 0.01 | < 0.01 |
| Hospital stay, day, median (IQR) | 21.5 (12.8–33.5) | 10.9 (5.9–20.3) | < 0.01 | < 0.01 |
| 28-day mortality rate, n (%) | 111 (39.6) | 105 (37.5) | 0.60 | 0.80 |
In multivariate regression analysis, possible influencing factors (including BMI, septic shock, blood sodium on admission, vasoactive drugs, and mechanical ventilation) were excluded.